Cargando…
Molecular mediators of peritoneal metastasis in pancreatic cancer
Pancreatic cancer is the third leading cause of cancer death in the USA, and pancreatic ductal adenocarcinoma (PDA) constitutes 85% of pancreatic cancer diagnoses. PDA frequently metastasizes to the peritoneum, but effective treatment of peritoneal metastasis remains a clinical challenge. Despite th...
Autores principales: | Avula, Leela Rani, Hagerty, Brendan, Alewine, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680314/ https://www.ncbi.nlm.nih.gov/pubmed/32780245 http://dx.doi.org/10.1007/s10555-020-09924-4 |
Ejemplares similares
-
Nanotechnology-aided advancement in the combating of cancer metastasis
por: Avula, Leela Rani, et al.
Publicado: (2022) -
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
por: Masoumi Moghaddam, Samar, et al.
Publicado: (2011) -
EPLIN: a fundamental actin regulator in cancer metastasis?
por: Collins, Ross J., et al.
Publicado: (2015) -
Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis
por: Sodek, Katharine L., et al.
Publicado: (2012) -
The non-coding transcriptome as a dynamic regulator of cancer metastasis
por: Crea, Francesco, et al.
Publicado: (2013)